Microcytic Hypochromic Anemia: Iron Deficiency Anemia
This patient has iron deficiency anemia (IDA), characterized by the classic triad of low hemoglobin (11.8 g/dL), microcytosis (MCV 73.4 fL), and hypochromia (MCH 22.7 pg, MCHC 31.0 g/dL), with elevated RDW (16.3%) indicating anisocytosis from mixed populations of iron-deficient and normal red cells. 1, 2
Diagnostic Confirmation Required
Order a complete iron panel immediately (serum ferritin, transferrin saturation, and C-reactive protein) because low MCH and MCHC indicate hypochromic anemia most commonly caused by iron deficiency, and these tests are required to confirm the diagnosis and guide treatment. 2
Iron Study Interpretation
- Ferritin <15 μg/L confirms absent iron stores; <30 μg/L indicates low body iron stores in patients without inflammation 2
- Transferrin saturation <16-20% supports iron deficiency and is less affected by inflammation than ferritin 2
- If CRP is elevated (indicating inflammation), use higher ferritin thresholds of 45-100 μg/L to diagnose iron deficiency, as ferritin is an acute-phase reactant that can mask true iron deficiency 2
- Ferritin >150 μg/L makes absolute iron deficiency unlikely even with inflammation 2
Differential Diagnosis When Iron Studies Are Normal
If iron studies are normal despite the microcytic hypochromic picture:
- Obtain hemoglobin electrophoresis to evaluate for thalassemia trait, especially in patients of Mediterranean, African, or Southeast Asian descent 2
- Thalassemia minor produces microcytic anemia with low MCHC but can be distinguished by a normal or low RDW (<14.0%), whereas this patient has elevated RDW (16.3%), making thalassemia less likely 1
- Consider anemia of chronic disease or sideroblastic anemia as alternative diagnoses 2
Treatment Protocol for Confirmed Iron Deficiency
First-Line: Oral Iron Therapy
Initiate ferrous sulfate 325 mg (65 mg elemental iron) once daily between meals, as recent evidence shows intermittent dosing is as effective as daily or twice-daily dosing with fewer side effects 3
- Expect hemoglobin increase of approximately 1-2 g/dL every 2-4 weeks 2
- Continue iron supplementation for 3-6 months after hemoglobin normalizes to replenish iron stores 2
- Check hemoglobin, reticulocytes, and iron studies after 4-8 weeks of therapy 2
- A rise in hemoglobin ≥1 g/dL within 2 weeks strongly confirms iron deficiency, even if initial iron studies were equivocal 2
Second-Line: Intravenous Iron
Consider parenteral iron if the patient is intolerant to oral iron, has poor response to oral iron, or has severe anemia requiring rapid correction 2
For IV iron administration:
- Ferric carboxymaltose 750 mg intravenously in two doses separated by at least 7 days (total cumulative dose 1,500 mg) for patients ≥50 kg 4
- For patients <50 kg, administer 15 mg/kg body weight in two doses separated by at least 7 days 4
- Monitor serum phosphate levels in patients requiring repeat courses within 3 months, as hypophosphatemia is a known complication 4
Mandatory Investigation of Underlying Cause
Do not forget to investigate the source of iron deficiency, as it often indicates ongoing blood loss requiring evaluation, particularly gastrointestinal bleeding or malabsorption 2
Key investigations include:
- Gastrointestinal evaluation (upper endoscopy and colonoscopy) for occult bleeding 2
- Menstrual history in women of reproductive age 3
- Dietary assessment for inadequate iron intake 5
- Celiac serology if malabsorption suspected 2
Critical Pitfalls to Avoid
- Do not rely on MCV alone, as iron deficiency can present with normal MCV in early stages, and MCH (which is low in this patient) may be more sensitive 2
- Do not dismiss normal ferritin in inflammatory states—use the higher cutoff of 45-100 μg/L depending on inflammation severity 2
- Do not use excessive "milking" of the finger during capillary blood sampling, as this contaminates blood with tissue fluid leading to falsely low hemoglobin readings 5
- Confirm low readings with a second sample before initiating treatment 5